Global Prostaglandin I2 Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Description

According to our (Global Info Research) latest study, the global Prostaglandin I2 market size was valued at USD 2528.1 million in 2022 and is forecast to a readjusted size of USD 3808.7 million by 2029 with a CAGR of 6.0% during review period.

Prostaglandin I2 (PGI), or prostacyclin, is one of the prostanoids, a group of local hormones that are best known for their roles in mediating inflammation.

The prostaglandin I2 (PGI2) market is driven by its critical role as a potent vasodilator and inhibitor of platelet aggregation, making it an essential therapeutic option for various cardiovascular conditions. PGI2, also known as prostacyclin, is used to treat pulmonary arterial hypertension (PAH), preventing blood clot formation and improving blood flow in affected patients. The increasing prevalence of PAH and the growing awareness of its therapeutic benefits contribute to market growth. Moreover, advancements in pharmaceutical research and biotechnology have led to the development of new formulations and delivery methods for PGI2, further expanding its application in cardiovascular medicine. However, the market also faces challenges, including the high cost of PGI2 therapy, which may limit patient access and affordability. Additionally, the need for continuous infusion in some cases and potential side effects, such as bleeding complications, can pose obstacles for widespread adoption. To succeed in this market, manufacturers must focus on cost-effectiveness, patient-friendly administration methods, and conducting extensive clinical trials to establish the safety and efficacy of PGI2 therapies for various cardiovascular conditions, ensuring its continued use as a critical treatment option.

The Global Info Research report includes an overview of the development of the Prostaglandin I2 industry chain, the market status of For Injection (Epoprostenol Sodium, Treprostinil), For Oral (Epoprostenol Sodium, Treprostinil), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Prostaglandin I2.

Regionally, the report analyzes the Prostaglandin I2 markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Prostaglandin I2 market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Prostaglandin I2 market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Prostaglandin I2 industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Epoprostenol Sodium, Treprostinil).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Prostaglandin I2 market.

Regional Analysis: The report involves examining the Prostaglandin I2 market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Prostaglandin I2 market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Prostaglandin I2:
Company Analysis: Report covers individual Prostaglandin I2 manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Prostaglandin I2 This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (For Injection, For Oral).

Technology Analysis: Report covers specific technologies relevant to Prostaglandin I2. It assesses the current state, advancements, and potential future developments in Prostaglandin I2 areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Prostaglandin I2 market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Prostaglandin I2 market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
    Epoprostenol Sodium
    Treprostinil
    Iloprost
    Beraprost Sodium

Market segment by Application
    For Injection
    For Oral
    For Inhalation

Major players covered
    United Therapeutics
    J & J
    GSK
    Teva
    Toray
    Tide Pharma
    Bayer AG

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Prostaglandin I2 product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Prostaglandin I2, with price, sales, revenue and global market share of Prostaglandin I2 from 2018 to 2023.
Chapter 3, the Prostaglandin I2 competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Prostaglandin I2 breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Prostaglandin I2 market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Prostaglandin I2.
Chapter 14 and 15, to describe Prostaglandin I2 sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Prostaglandin I2
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Prostaglandin I2 Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Epoprostenol Sodium
        1.3.3 Treprostinil
        1.3.4 Iloprost
        1.3.5 Beraprost Sodium
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Prostaglandin I2 Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 For Injection
        1.4.3 For Oral
        1.4.4 For Inhalation
    1.5 Global Prostaglandin I2 Market Size & Forecast
        1.5.1 Global Prostaglandin I2 Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Prostaglandin I2 Sales Quantity (2018-2029)
        1.5.3 Global Prostaglandin I2 Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 United Therapeutics
        2.1.1 United Therapeutics Details
        2.1.2 United Therapeutics Major Business
        2.1.3 United Therapeutics Prostaglandin I2 Product and Services
        2.1.4 United Therapeutics Prostaglandin I2 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 United Therapeutics Recent Developments/Updates
    2.2 J & J
        2.2.1 J & J Details
        2.2.2 J & J Major Business
        2.2.3 J & J Prostaglandin I2 Product and Services
        2.2.4 J & J Prostaglandin I2 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 J & J Recent Developments/Updates
    2.3 GSK
        2.3.1 GSK Details
        2.3.2 GSK Major Business
        2.3.3 GSK Prostaglandin I2 Product and Services
        2.3.4 GSK Prostaglandin I2 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 GSK Recent Developments/Updates
    2.4 Teva
        2.4.1 Teva Details
        2.4.2 Teva Major Business
        2.4.3 Teva Prostaglandin I2 Product and Services
        2.4.4 Teva Prostaglandin I2 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Teva Recent Developments/Updates
    2.5 Toray
        2.5.1 Toray Details
        2.5.2 Toray Major Business
        2.5.3 Toray Prostaglandin I2 Product and Services
        2.5.4 Toray Prostaglandin I2 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Toray Recent Developments/Updates
    2.6 Tide Pharma
        2.6.1 Tide Pharma Details
        2.6.2 Tide Pharma Major Business
        2.6.3 Tide Pharma Prostaglandin I2 Product and Services
        2.6.4 Tide Pharma Prostaglandin I2 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Tide Pharma Recent Developments/Updates
    2.7 Bayer AG
        2.7.1 Bayer AG Details
        2.7.2 Bayer AG Major Business
        2.7.3 Bayer AG Prostaglandin I2 Product and Services
        2.7.4 Bayer AG Prostaglandin I2 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Bayer AG Recent Developments/Updates

3 Competitive Environment: Prostaglandin I2 by Manufacturer
    3.1 Global Prostaglandin I2 Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Prostaglandin I2 Revenue by Manufacturer (2018-2023)
    3.3 Global Prostaglandin I2 Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Prostaglandin I2 by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Prostaglandin I2 Manufacturer Market Share in 2022
        3.4.2 Top 6 Prostaglandin I2 Manufacturer Market Share in 2022
    3.5 Prostaglandin I2 Market: Overall Company Footprint Analysis
        3.5.1 Prostaglandin I2 Market: Region Footprint
        3.5.2 Prostaglandin I2 Market: Company Product Type Footprint
        3.5.3 Prostaglandin I2 Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Prostaglandin I2 Market Size by Region
        4.1.1 Global Prostaglandin I2 Sales Quantity by Region (2018-2029)
        4.1.2 Global Prostaglandin I2 Consumption Value by Region (2018-2029)
        4.1.3 Global Prostaglandin I2 Average Price by Region (2018-2029)
    4.2 North America Prostaglandin I2 Consumption Value (2018-2029)
    4.3 Europe Prostaglandin I2 Consumption Value (2018-2029)
    4.4 Asia-Pacific Prostaglandin I2 Consumption Value (2018-2029)
    4.5 South America Prostaglandin I2 Consumption Value (2018-2029)
    4.6 Middle East and Africa Prostaglandin I2 Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Prostaglandin I2 Sales Quantity by Type (2018-2029)
    5.2 Global Prostaglandin I2 Consumption Value by Type (2018-2029)
    5.3 Global Prostaglandin I2 Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Prostaglandin I2 Sales Quantity by Application (2018-2029)
    6.2 Global Prostaglandin I2 Consumption Value by Application (2018-2029)
    6.3 Global Prostaglandin I2 Average Price by Application (2018-2029)

7 North America
    7.1 North America Prostaglandin I2 Sales Quantity by Type (2018-2029)
    7.2 North America Prostaglandin I2 Sales Quantity by Application (2018-2029)
    7.3 North America Prostaglandin I2 Market Size by Country
        7.3.1 North America Prostaglandin I2 Sales Quantity by Country (2018-2029)
        7.3.2 North America Prostaglandin I2 Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Prostaglandin I2 Sales Quantity by Type (2018-2029)
    8.2 Europe Prostaglandin I2 Sales Quantity by Application (2018-2029)
    8.3 Europe Prostaglandin I2 Market Size by Country
        8.3.1 Europe Prostaglandin I2 Sales Quantity by Country (2018-2029)
        8.3.2 Europe Prostaglandin I2 Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Prostaglandin I2 Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Prostaglandin I2 Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Prostaglandin I2 Market Size by Region
        9.3.1 Asia-Pacific Prostaglandin I2 Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Prostaglandin I2 Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Prostaglandin I2 Sales Quantity by Type (2018-2029)
    10.2 South America Prostaglandin I2 Sales Quantity by Application (2018-2029)
    10.3 South America Prostaglandin I2 Market Size by Country
        10.3.1 South America Prostaglandin I2 Sales Quantity by Country (2018-2029)
        10.3.2 South America Prostaglandin I2 Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Prostaglandin I2 Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Prostaglandin I2 Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Prostaglandin I2 Market Size by Country
        11.3.1 Middle East & Africa Prostaglandin I2 Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Prostaglandin I2 Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Prostaglandin I2 Market Drivers
    12.2 Prostaglandin I2 Market Restraints
    12.3 Prostaglandin I2 Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Prostaglandin I2 and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Prostaglandin I2
    13.3 Prostaglandin I2 Production Process
    13.4 Prostaglandin I2 Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Prostaglandin I2 Typical Distributors
    14.3 Prostaglandin I2 Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Prostaglandin I2 Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Prostaglandin I2 Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. United Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 4. United Therapeutics Major Business
    Table 5. United Therapeutics Prostaglandin I2 Product and Services
    Table 6. United Therapeutics Prostaglandin I2 Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. United Therapeutics Recent Developments/Updates
    Table 8. J & J Basic Information, Manufacturing Base and Competitors
    Table 9. J & J Major Business
    Table 10. J & J Prostaglandin I2 Product and Services
    Table 11. J & J Prostaglandin I2 Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. J & J Recent Developments/Updates
    Table 13. GSK Basic Information, Manufacturing Base and Competitors
    Table 14. GSK Major Business
    Table 15. GSK Prostaglandin I2 Product and Services
    Table 16. GSK Prostaglandin I2 Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. GSK Recent Developments/Updates
    Table 18. Teva Basic Information, Manufacturing Base and Competitors
    Table 19. Teva Major Business
    Table 20. Teva Prostaglandin I2 Product and Services
    Table 21. Teva Prostaglandin I2 Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Teva Recent Developments/Updates
    Table 23. Toray Basic Information, Manufacturing Base and Competitors
    Table 24. Toray Major Business
    Table 25. Toray Prostaglandin I2 Product and Services
    Table 26. Toray Prostaglandin I2 Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. Toray Recent Developments/Updates
    Table 28. Tide Pharma Basic Information, Manufacturing Base and Competitors
    Table 29. Tide Pharma Major Business
    Table 30. Tide Pharma Prostaglandin I2 Product and Services
    Table 31. Tide Pharma Prostaglandin I2 Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. Tide Pharma Recent Developments/Updates
    Table 33. Bayer AG Basic Information, Manufacturing Base and Competitors
    Table 34. Bayer AG Major Business
    Table 35. Bayer AG Prostaglandin I2 Product and Services
    Table 36. Bayer AG Prostaglandin I2 Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. Bayer AG Recent Developments/Updates
    Table 38. Global Prostaglandin I2 Sales Quantity by Manufacturer (2018-2023) & (K Units)
    Table 39. Global Prostaglandin I2 Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 40. Global Prostaglandin I2 Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 41. Market Position of Manufacturers in Prostaglandin I2, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 42. Head Office and Prostaglandin I2 Production Site of Key Manufacturer
    Table 43. Prostaglandin I2 Market: Company Product Type Footprint
    Table 44. Prostaglandin I2 Market: Company Product Application Footprint
    Table 45. Prostaglandin I2 New Market Entrants and Barriers to Market Entry
    Table 46. Prostaglandin I2 Mergers, Acquisition, Agreements, and Collaborations
    Table 47. Global Prostaglandin I2 Sales Quantity by Region (2018-2023) & (K Units)
    Table 48. Global Prostaglandin I2 Sales Quantity by Region (2024-2029) & (K Units)
    Table 49. Global Prostaglandin I2 Consumption Value by Region (2018-2023) & (USD Million)
    Table 50. Global Prostaglandin I2 Consumption Value by Region (2024-2029) & (USD Million)
    Table 51. Global Prostaglandin I2 Average Price by Region (2018-2023) & (US$/Unit)
    Table 52. Global Prostaglandin I2 Average Price by Region (2024-2029) & (US$/Unit)
    Table 53. Global Prostaglandin I2 Sales Quantity by Type (2018-2023) & (K Units)
    Table 54. Global Prostaglandin I2 Sales Quantity by Type (2024-2029) & (K Units)
    Table 55. Global Prostaglandin I2 Consumption Value by Type (2018-2023) & (USD Million)
    Table 56. Global Prostaglandin I2 Consumption Value by Type (2024-2029) & (USD Million)
    Table 57. Global Prostaglandin I2 Average Price by Type (2018-2023) & (US$/Unit)
    Table 58. Global Prostaglandin I2 Average Price by Type (2024-2029) & (US$/Unit)
    Table 59. Global Prostaglandin I2 Sales Quantity by Application (2018-2023) & (K Units)
    Table 60. Global Prostaglandin I2 Sales Quantity by Application (2024-2029) & (K Units)
    Table 61. Global Prostaglandin I2 Consumption Value by Application (2018-2023) & (USD Million)
    Table 62. Global Prostaglandin I2 Consumption Value by Application (2024-2029) & (USD Million)
    Table 63. Global Prostaglandin I2 Average Price by Application (2018-2023) & (US$/Unit)
    Table 64. Global Prostaglandin I2 Average Price by Application (2024-2029) & (US$/Unit)
    Table 65. North America Prostaglandin I2 Sales Quantity by Type (2018-2023) & (K Units)
    Table 66. North America Prostaglandin I2 Sales Quantity by Type (2024-2029) & (K Units)
    Table 67. North America Prostaglandin I2 Sales Quantity by Application (2018-2023) & (K Units)
    Table 68. North America Prostaglandin I2 Sales Quantity by Application (2024-2029) & (K Units)
    Table 69. North America Prostaglandin I2 Sales Quantity by Country (2018-2023) & (K Units)
    Table 70. North America Prostaglandin I2 Sales Quantity by Country (2024-2029) & (K Units)
    Table 71. North America Prostaglandin I2 Consumption Value by Country (2018-2023) & (USD Million)
    Table 72. North America Prostaglandin I2 Consumption Value by Country (2024-2029) & (USD Million)
    Table 73. Europe Prostaglandin I2 Sales Quantity by Type (2018-2023) & (K Units)
    Table 74. Europe Prostaglandin I2 Sales Quantity by Type (2024-2029) & (K Units)
    Table 75. Europe Prostaglandin I2 Sales Quantity by Application (2018-2023) & (K Units)
    Table 76. Europe Prostaglandin I2 Sales Quantity by Application (2024-2029) & (K Units)
    Table 77. Europe Prostaglandin I2 Sales Quantity by Country (2018-2023) & (K Units)
    Table 78. Europe Prostaglandin I2 Sales Quantity by Country (2024-2029) & (K Units)
    Table 79. Europe Prostaglandin I2 Consumption Value by Country (2018-2023) & (USD Million)
    Table 80. Europe Prostaglandin I2 Consumption Value by Country (2024-2029) & (USD Million)
    Table 81. Asia-Pacific Prostaglandin I2 Sales Quantity by Type (2018-2023) & (K Units)
    Table 82. Asia-Pacific Prostaglandin I2 Sales Quantity by Type (2024-2029) & (K Units)
    Table 83. Asia-Pacific Prostaglandin I2 Sales Quantity by Application (2018-2023) & (K Units)
    Table 84. Asia-Pacific Prostaglandin I2 Sales Quantity by Application (2024-2029) & (K Units)
    Table 85. Asia-Pacific Prostaglandin I2 Sales Quantity by Region (2018-2023) & (K Units)
    Table 86. Asia-Pacific Prostaglandin I2 Sales Quantity by Region (2024-2029) & (K Units)
    Table 87. Asia-Pacific Prostaglandin I2 Consumption Value by Region (2018-2023) & (USD Million)
    Table 88. Asia-Pacific Prostaglandin I2 Consumption Value by Region (2024-2029) & (USD Million)
    Table 89. South America Prostaglandin I2 Sales Quantity by Type (2018-2023) & (K Units)
    Table 90. South America Prostaglandin I2 Sales Quantity by Type (2024-2029) & (K Units)
    Table 91. South America Prostaglandin I2 Sales Quantity by Application (2018-2023) & (K Units)
    Table 92. South America Prostaglandin I2 Sales Quantity by Application (2024-2029) & (K Units)
    Table 93. South America Prostaglandin I2 Sales Quantity by Country (2018-2023) & (K Units)
    Table 94. South America Prostaglandin I2 Sales Quantity by Country (2024-2029) & (K Units)
    Table 95. South America Prostaglandin I2 Consumption Value by Country (2018-2023) & (USD Million)
    Table 96. South America Prostaglandin I2 Consumption Value by Country (2024-2029) & (USD Million)
    Table 97. Middle East & Africa Prostaglandin I2 Sales Quantity by Type (2018-2023) & (K Units)
    Table 98. Middle East & Africa Prostaglandin I2 Sales Quantity by Type (2024-2029) & (K Units)
    Table 99. Middle East & Africa Prostaglandin I2 Sales Quantity by Application (2018-2023) & (K Units)
    Table 100. Middle East & Africa Prostaglandin I2 Sales Quantity by Application (2024-2029) & (K Units)
    Table 101. Middle East & Africa Prostaglandin I2 Sales Quantity by Region (2018-2023) & (K Units)
    Table 102. Middle East & Africa Prostaglandin I2 Sales Quantity by Region (2024-2029) & (K Units)
    Table 103. Middle East & Africa Prostaglandin I2 Consumption Value by Region (2018-2023) & (USD Million)
    Table 104. Middle East & Africa Prostaglandin I2 Consumption Value by Region (2024-2029) & (USD Million)
    Table 105. Prostaglandin I2 Raw Material
    Table 106. Key Manufacturers of Prostaglandin I2 Raw Materials
    Table 107. Prostaglandin I2 Typical Distributors
    Table 108. Prostaglandin I2 Typical Customers
List of Figures
    Figure 1. Prostaglandin I2 Picture
    Figure 2. Global Prostaglandin I2 Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Prostaglandin I2 Consumption Value Market Share by Type in 2022
    Figure 4. Epoprostenol Sodium Examples
    Figure 5. Treprostinil Examples
    Figure 6. Iloprost Examples
    Figure 7. Beraprost Sodium Examples
    Figure 8. Global Prostaglandin I2 Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 9. Global Prostaglandin I2 Consumption Value Market Share by Application in 2022
    Figure 10. For Injection Examples
    Figure 11. For Oral Examples
    Figure 12. For Inhalation Examples
    Figure 13. Global Prostaglandin I2 Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 14. Global Prostaglandin I2 Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 15. Global Prostaglandin I2 Sales Quantity (2018-2029) & (K Units)
    Figure 16. Global Prostaglandin I2 Average Price (2018-2029) & (US$/Unit)
    Figure 17. Global Prostaglandin I2 Sales Quantity Market Share by Manufacturer in 2022
    Figure 18. Global Prostaglandin I2 Consumption Value Market Share by Manufacturer in 2022
    Figure 19. Producer Shipments of Prostaglandin I2 by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 20. Top 3 Prostaglandin I2 Manufacturer (Consumption Value) Market Share in 2022
    Figure 21. Top 6 Prostaglandin I2 Manufacturer (Consumption Value) Market Share in 2022
    Figure 22. Global Prostaglandin I2 Sales Quantity Market Share by Region (2018-2029)
    Figure 23. Global Prostaglandin I2 Consumption Value Market Share by Region (2018-2029)
    Figure 24. North America Prostaglandin I2 Consumption Value (2018-2029) & (USD Million)
    Figure 25. Europe Prostaglandin I2 Consumption Value (2018-2029) & (USD Million)
    Figure 26. Asia-Pacific Prostaglandin I2 Consumption Value (2018-2029) & (USD Million)
    Figure 27. South America Prostaglandin I2 Consumption Value (2018-2029) & (USD Million)
    Figure 28. Middle East & Africa Prostaglandin I2 Consumption Value (2018-2029) & (USD Million)
    Figure 29. Global Prostaglandin I2 Sales Quantity Market Share by Type (2018-2029)
    Figure 30. Global Prostaglandin I2 Consumption Value Market Share by Type (2018-2029)
    Figure 31. Global Prostaglandin I2 Average Price by Type (2018-2029) & (US$/Unit)
    Figure 32. Global Prostaglandin I2 Sales Quantity Market Share by Application (2018-2029)
    Figure 33. Global Prostaglandin I2 Consumption Value Market Share by Application (2018-2029)
    Figure 34. Global Prostaglandin I2 Average Price by Application (2018-2029) & (US$/Unit)
    Figure 35. North America Prostaglandin I2 Sales Quantity Market Share by Type (2018-2029)
    Figure 36. North America Prostaglandin I2 Sales Quantity Market Share by Application (2018-2029)
    Figure 37. North America Prostaglandin I2 Sales Quantity Market Share by Country (2018-2029)
    Figure 38. North America Prostaglandin I2 Consumption Value Market Share by Country (2018-2029)
    Figure 39. United States Prostaglandin I2 Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 40. Canada Prostaglandin I2 Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 41. Mexico Prostaglandin I2 Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 42. Europe Prostaglandin I2 Sales Quantity Market Share by Type (2018-2029)
    Figure 43. Europe Prostaglandin I2 Sales Quantity Market Share by Application (2018-2029)
    Figure 44. Europe Prostaglandin I2 Sales Quantity Market Share by Country (2018-2029)
    Figure 45. Europe Prostaglandin I2 Consumption Value Market Share by Country (2018-2029)
    Figure 46. Germany Prostaglandin I2 Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. France Prostaglandin I2 Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. United Kingdom Prostaglandin I2 Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. Russia Prostaglandin I2 Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 50. Italy Prostaglandin I2 Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 51. Asia-Pacific Prostaglandin I2 Sales Quantity Market Share by Type (2018-2029)
    Figure 52. Asia-Pacific Prostaglandin I2 Sales Quantity Market Share by Application (2018-2029)
    Figure 53. Asia-Pacific Prostaglandin I2 Sales Quantity Market Share by Region (2018-2029)
    Figure 54. Asia-Pacific Prostaglandin I2 Consumption Value Market Share by Region (2018-2029)
    Figure 55. China Prostaglandin I2 Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. Japan Prostaglandin I2 Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. Korea Prostaglandin I2 Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. India Prostaglandin I2 Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. Southeast Asia Prostaglandin I2 Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 60. Australia Prostaglandin I2 Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 61. South America Prostaglandin I2 Sales Quantity Market Share by Type (2018-2029)
    Figure 62. South America Prostaglandin I2 Sales Quantity Market Share by Application (2018-2029)
    Figure 63. South America Prostaglandin I2 Sales Quantity Market Share by Country (2018-2029)
    Figure 64. South America Prostaglandin I2 Consumption Value Market Share by Country (2018-2029)
    Figure 65. Brazil Prostaglandin I2 Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 66. Argentina Prostaglandin I2 Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 67. Middle East & Africa Prostaglandin I2 Sales Quantity Market Share by Type (2018-2029)
    Figure 68. Middle East & Africa Prostaglandin I2 Sales Quantity Market Share by Application (2018-2029)
    Figure 69. Middle East & Africa Prostaglandin I2 Sales Quantity Market Share by Region (2018-2029)
    Figure 70. Middle East & Africa Prostaglandin I2 Consumption Value Market Share by Region (2018-2029)
    Figure 71. Turkey Prostaglandin I2 Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. Egypt Prostaglandin I2 Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. Saudi Arabia Prostaglandin I2 Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 74. South Africa Prostaglandin I2 Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 75. Prostaglandin I2 Market Drivers
    Figure 76. Prostaglandin I2 Market Restraints
    Figure 77. Prostaglandin I2 Market Trends
    Figure 78. Porters Five Forces Analysis
    Figure 79. Manufacturing Cost Structure Analysis of Prostaglandin I2 in 2022
    Figure 80. Manufacturing Process Analysis of Prostaglandin I2
    Figure 81. Prostaglandin I2 Industrial Chain
    Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 83. Direct Channel Pros & Cons
    Figure 84. Indirect Channel Pros & Cons
    Figure 85. Methodology
    Figure 86. Research Process and Data Source

Companies Mentioned

United Therapeutics
J & J
GSK
Teva
Toray
Tide Pharma
Bayer AG